FDA approval numbers show it approved 23 novel drugs during the first six months of 2026, maintaining a pace that would be consistent with recent years despite an unusually turbulent period marked by leadership and staff turnover.
FDA selects seven companies from 80 applications to participate in the agency’s PreCheck Pilot Program to advance U.S. drug manufacturing.
FDA approval numbers show it approved 23 novel drugs during the first six months of 2026, maintaining a pace that would be consistent with recent years despite an unusually turbulent period marked by leadership and staff turnover.
FDA selects seven companies from 80 applications to participate in the agency’s PreCheck Pilot Program to advance U.S. drug manufacturing.
FDA warns Genzyme Ireland about the failure of the firm’s quality control unit to ensure that drugs comply with CGMP requirements.
During a CBS News interview, former CDC chief medical officer Debra Houry says she left the agency after concluding she could no longer defend its scientific integrity, citing widespread political interference in a number of areas.
